Ok, im confused abit here, this was brought up on
Post# of 5066
Posted On: 06/13/2013 2:28:52 PM
Ok, im confused abit here, this was brought up on that other board and im investigating this.
The recent 8K was about the Min Gene Silencing, BUT! if you go down and look at the time line in section 6, its not the same science? Anyone care to put in there two cents? Im getting kind of excited because this looks like deal number 3!
| 6.1 | Diligence. Licensee will use its reasonable best efforts to develop, manufacture or have manufactured, market and sell Licensed Products as soon as practicable consistent with reasonable business practices and judgment and any obligations to the U.S. government specified in Section 3.3 including:: |
| 6.1.1 | Identification of optimum embodiment of patent claims for clinical development (e.g.: utilization of endothelial cells from bone marrow versus placenta, versus adipose stromal vascular fraction) by August 2013 |
| 6.1.2 | Creation of white paper in peer reviewed journal comparing hematopoietic stimulatory activity of endothelial cells from different tissues of the body. This puts forth the scientific rationale for the project by September 2013 |
| 6.1.3 | Selection of manufacturing facility and development of Good Manufacturing Practice (GMP) protocol for creation of preclinical samples for experimentation by October 2013. |
| 6.1.4 | Establishment of preclinical animal model to replicate patient data using cells produced according to Regen standard operating procedures by December 2013 |
| 6.1.5 | Recruitment of Principal Investigator for Clinical Trial by February 2014. |
| 6.1.6 | Compilation of preclinical efficacy and safety data for IND generation by April 2014 |
| 6.1.7 | Submission of IND application to FDA by May 2014 |
Am i looking for something thats not there?
(0)
(0)RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼